Homocysteine modulates sodium channel currents in human atrial myocytes

Benzhi Cai1, Luchen Shan, Dongmei Gong

  • 1Department of Pharmacology, Harbin Medical University, Baojian Road 157, Harbin 150081, PR China.

Toxicology
|December 27, 2008
PubMed

Insights

High homocysteine levels in the blood disrupt heart cell sodium channels, increasing the risk of arrhythmias and ischemia. This study reveals how homocysteine affects these critical cardiac ion channels.

Area of Science:

  • Cardiology
  • Molecular Biology
  • Electrophysiology

Background:

  • Hyperhomocysteinemia is a suspected risk factor for cardiac arrhythmias and ischemia.
  • The precise cellular mechanisms of homocysteine's cardiac toxicity are not fully understood.
  • Aberrant sodium channel function is implicated in cardiac arrhythmias and ischemic injury.

Purpose of the Study:

  • To investigate the toxic effects of homocysteine on cardiac sodium currents in human atrial cells.
  • To elucidate the cellular mechanisms linking hyperhomocysteinemia to cardiac dysfunction.

Main Methods:

  • Human atrial myocytes were isolated using enzymatic dissociation.
  • Whole-cell patch clamp technique was used to record sodium currents and membrane potential.
  • Experiments were conducted with and without varying concentrations of homocysteine.

Main Results:

  • Pathological homocysteine concentrations significantly increased sodium currents and depolarized resting membrane potential.
  • Homocysteine shortened time constants for sodium current activation and inactivation.
  • Elevated homocysteine shifted the inactivation curve positively and accelerated recovery from inactivation, without affecting activation.

Conclusions:

  • Increased homocysteine levels induce abnormalities in human atrial cell sodium currents.
  • These alterations involve slowed inactivation and promoted recovery of sodium channels.
  • Findings provide insight into the mechanisms of hyperhomocysteinemia-associated cardiac arrhythmias and ischemia.

Related Concept Videos

Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers01:22

Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers

Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Voltage-gated Ion Channels01:26

Voltage-gated Ion Channels

Voltage-gated ion channels are transmembrane proteins that open and close in response to changes in the membrane potential. They are present on the membranes of all electrically excitable cells such as neurons, heart, and muscle cells.
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several types of...
Antihypertensive Drugs: Action of Calcium Channel Blockers01:18

Antihypertensive Drugs: Action of Calcium Channel Blockers

Calcium ions are essential to contract smooth muscle cells in blood vessels. They enter these cells through voltage-dependent calcium channels, specifically L-type calcium channels in the cell membrane. These L-type calcium channels are integral to the excitation-contraction coupling process in smooth muscle. When a stimulus is received by smooth muscle cells, their membrane depolarizes. This alteration in membrane potential instigates the opening of L-type calcium channels. As a result,...
Mechanism of Cardiac Arrhythmias01:28

Mechanism of Cardiac Arrhythmias

Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
Regulation of Sodium and Potassium01:26

Regulation of Sodium and Potassium

The regulation of sodium and potassium ion concentrations in the human body is a complex process governed primarily by hormones such as aldosterone, antidiuretic hormone (ADH), and atrial natriuretic peptide (ANP).
Sodium Regulation
Sodium ions make up approximately 90% of extracellular cations, with a normal blood plasma concentration of 136–148 mEq/L. A decrease in blood volume and pressure triggers the release of renin from granular cells in the juxtaglomerular complex (JGC), primarily in...
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers01:12

Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers

Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of the heart's...